Sunesis And Chiesi Enter Drug Discovery Agreement

chiesiSunesis Pharmaceuticals, Inc. and Chiesi Farmaceutici S.p.A have entered into a research collaboration to discover and develop small molecules that inhibit a well-validated protein-protein target involved in immunological diseases.

Using its proprietary discovery technology, Sunesis will generate development candidates and Chiesi will have an exclusive option to enter into an exclusive license to develop and market resulting products in Europe, Latin America, and other selected countries where Chiesi has a presence.

Sunesis will retain exclusive rights in North America, Japan and other countries.

Under the terms of the agreement, Sunesis will receive upfront payments, research funding, research and development milestones, and royalty payments based on sales.

The total value of the deal would range between $22 and $30 million and could exceed this depending on the number of indications and compounds, excluding royalties.

Dr. James Young, CEO of Sunesis, commented, “This relationship is a very important first collaboration for Sunesis for a couple of reasons. First, it allows us to work on a key protein-protein target that addresses large therapeutic markets, such as rheumatoid arthritis, with a company that has strong development expertise in these indications. Second, it validates an important component of Sunesis’ business strategy, which is to partner some programs regionally and retain rights to others. This agreement satisfies both of these goals in that we receive the benefit of Chiesi’s research funding, development capabilities and data, and marketing expertise in Europe, while retaining rights in the US and Japan. We are very pleased to be working with Chiesi, one of the fastest growing and most forward-thinking companies in Europe.”

Dr. Paolo Chiesi, Group Vice President and R&D Director of Chiesi, stated, “This agreement represents a major opportunity for Chiesi to have access to a very innovative technology which could enrich our pipeline in a therapeutic area in which the medical needs are still unsatisfied, and in which Chiesi has a strong history.”

Sunesis utilizes a revolutionary approach to drug discovery based on novel technologies that deliver high-affinity, small molecule, non- peptidic ligands to important drug targets in a rapid time frame.

Chiesi Farmaceutici is a European pharmaceutical company, headquartered in Parma, Italy, dedicated to the research, development, and commercialization of ethical therapeutic products.

The core business includes musculoskeletal, respiratory, cardiovascular, and CNS.

Top Steroids

Dragon Pharma is a pharmaceutical company: Shop Parabolan 100 – manufacturing and exporting from Europe.

Obtain Dragon Pharmaceutical

TriTren 150 - Cheap Price

Administration: Injection
Basic Constituent: Tri Trenbolone
Manufacturer: Dragon Pharmaceutical
Pack: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $65.00

Sustanon 350 - Cheap Price

Administration: Injection
Prime Constituent: Testosterone Blend
Made by: Dragon Pharma
Pack: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00


Selective Estrogen Receptor Modulator
Main Substance: Tamoxifen Citrate
Branded by: Dragon Pharma LLC
Pack: 1 X 100 pastilles (20 mg/pastille)

Propionat 100

Injectable Anabolic Steroid
Basal Component: Testosterone Propionate
Made by: Dragon Pharma Labs
Pack: 1 X 10 ml (100 mg/ml)

Propionat 100 - Discount Price

Administration: Injection
Basal Chemical Name: Testosterone Propionate
Producer: Dragon Pharma
Package: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $20.00

NPP 150 - Discount Price

Administration: Injection
Basic Substance: Nandrolone Phenylpropionate
Producer: Dragon Pharma LLC
Package: 30 x 10 mL vial (150 mg/mL)
Price: 30 x $21.00

Cut Mix 150

Injectable Steroid for Muscle Growth
Mix of: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Branded by: Dragon Pharma
10 mL Sterile Multi-dose Vial (150 mg/mL)

EQ 200 / Test E 200

Injectable Steroid for Muscle Growth
Mix of: Boldenone Undecylenate, Testosterone Enanthate
Producer: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (400 mg/mL)

Cut Mix 150

Main Chemical Name: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Produced by: Dragon Pharma
Amount: 10 x 10 mL vial (150 mg/mL)

TriTren 150

Main Chemical Name: Tri Trenbolone
Manufacturer: Dragon Pharma LLC
Amount: 10 mL vial (150 mg/mL)

Winstrol 50

Main Component: Stanozolol
Producer: Dragon Pharmaceuticals
Unit: 10 mL vial (50 mg/mL)


Manufacturer: Dragon Pharmaceuticals
Main Substance: Methandrostenolone
Package: 100 tablets (20 mg/pill)